Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of linear amplification of tumor RNA from pancreatic tumor fine-needle aspirates
NL-OMON34795Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial in pancreatic adenocarcinoma (PDAC) and pancreatic cancer (PC), sponsored by Amsterdam University Medical Center. Primary endpoint: Amplified RNA quality. Planned start Sep 2010; status: not yet recruiting.
02
Conditions
pancreatic adenocarcinoma (PDAC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON34795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34795.